The Relationship between Serum Amyloid A Level and Cognitive Dysfunction in Patients with Vascular Dementia: Preliminary Findings

The Relationship between Serum Amyloid A Level and Cognitive Dysfunction in Patients with Vascular Dementia: Preliminary Findings

Objective. This study was aimed at investigating the relationship between serum amyloid A (SAA) levels and cognitive dysfunction in patients with vascular dementia (VAD). Methods. Using cross-sectional research methods, 146 patients with VAD were selected as the VAD group and 70 normal people were s...

Full description

Bibliographic Details
Main Authors:	Min Xu, Xiao-ying He, Pan Huang
Format:	Article
Language:	English
Published:	Hindawi Limited 2021-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2021/6676144

Similar Items

Increased Levels of Serum Neuregulin 1 Associated with Cognitive Impairment in Vascular Dementia
by: Xiaoling Wang, et al.
Published: (2020-01-01)

Decreased Serum NCAM Levels Associated with Cognitive Impairment in Vascular Dementia
by: Jun Zhao, et al.
Published: (2021-01-01)

Elevated Levels of Serum Neurofilament Light Chain Associated with Cognitive Impairment in Vascular Dementia
by: Weibin Ma, et al.
Published: (2020-01-01)

Decreased Levels of Serum IL-34 Associated with Cognitive Impairment in Vascular Dementia
by: Yang Wang, et al.
Published: (2021-01-01)

Salivary beta amyloid protein levels are detectable and differentiate patients with Alzheimer’s disease dementia from normal controls: preliminary findings
by: Marwan N Sabbagh, et al.
Published: (2018-09-01)

The impact of education on cortical thickness in amyloid-negative subcortical vascular dementia: cognitive reserve hypothesis
by: Na-Yeon Jung, et al.
Published: (2018-09-01)

Association of Serum FAM19A5 with Cognitive Impairment in Vascular Dementia
by: Juan Li, et al.
Published: (2020-01-01)

Serum Irisin as a Potential Biomarker for Cognitive Decline in Vascular Dementia
by: Feng Zhang, et al.
Published: (2021-09-01)

Vascular cognitive impairment and vascular dementia
by: Klavdija Ovčar, et al.
Published: (2017-09-01)

Efficacy Of Rivastigmine And Donepezil On Cognitive Impairment Of Vascular Dementia - Some Preliminary Observations
by: Jha S, et al.
Published: (2004-01-01)

Association between serum NPTX2 and cognitive function in patients with vascular dementia
by: Keke Shao, et al.
Published: (2020-10-01)

Acupuncture Can Regulate the Peripheral Immune Cell Spectrum and Inflammatory Environment of the Vascular Dementia Rat, and Improve the Cognitive Dysfunction of the Rats
by: Pan Pan, et al.
Published: (2021-07-01)

Neurovascular dysfunction in vascular dementia, Alzheimer’s and atherosclerosis
by: Osman Shabir, et al.
Published: (2018-10-01)

Astaxanthin protects cognitive function of vascular dementia
by: Ningwei Zhu, et al.
Published: (2020-11-01)

Rerecognition of vascular dementia and vascular cognitive impairment
by: Zhen HONG
Published: (2010-06-01)

Cognitive dysfunction and dementia in movement disorders
by: Egberto Reis Barbosa, et al.

Puerarin Alleviates Vascular Cognitive Impairment in Vascular Dementia Rats
by: Huang, N., et al.
Published: (2021)

Pattern of cognitive deficits in vascular dementia
by: Prasenjit Sengupta, et al.
Published: (2019-01-01)

Dysfunction of Cerebrovascular Endothelial Cells: Prelude to Vascular Dementia
by: Feixue Wang, et al.
Published: (2018-11-01)

Effects of fluoxetine on brain-derived neurotrophic factor serum concentration and cognition in patients with vascular dementia
by: Liu X, et al.
Published: (2014-03-01)

High-Density Lipoprotein (HDL) Inhibits Serum Amyloid A (SAA)-Induced Vascular and Renal Dysfunctions in Apolipoprotein E-Deficient Mice
by: Xiaoping Cai, et al.
Published: (2020-02-01)

Serum Amyloid A Stimulates Vascular and Renal Dysfunction in Apolipoprotein E-Deficient Mice Fed a Normal Chow Diet
by: Belal Chami, et al.
Published: (2019-03-01)

Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia
by: Ramon Cacabelos
Published: (2020-04-01)

Vascular depression and cognitive dysfunction
by: A. N. Bogolepova
Published: (2019-06-01)

Serum cystatin C levels are negatively correlated with post-stroke cognitive dysfunction
by: Dao-Xia Guo, et al.
Published: (2020-01-01)

Reduced serum lipid levels in patients receiving ECT - preliminary findings
by: A. Stautland, et al.
Published: (2017-03-01)

ESC‐sEVs Rejuvenate Senescent Hippocampal NSCs by Activating Lysosomes to Improve Cognitive Dysfunction in Vascular Dementia
by: Guowen Hu, et al.
Published: (2020-05-01)

Effects of CREB1 gene silencing on cognitive dysfunction by mediating PKA-CREB signaling pathway in mice with vascular dementia
by: Xin-Rui Han, et al.
Published: (2018-05-01)

Posterior atrophy predicts time to dementia in patients with amyloid-positive mild cognitive impairment
by: Jung-Min Pyun, et al.
Published: (2017-12-01)

Effect of butyl phthalide on serum cytokines, soluble apoptosis factors and antioxidant molecules in patients with vascular dementia
by: Jian-Min Wang, et al.
Published: (2017-03-01)

Beta-amyloid imaging in dementia
by: Kyung Ah Chun
Published: (2018-06-01)

Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression
by: Hong-Chun Wei, et al.
Published: (2021-07-01)

Cognitive dysfunction in idiopathic and vascular parkinsonism
by: Ivanka Štenc Bradvica, et al.
Published: (2011-08-01)

Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's disease
by: Ilaria eCanobbio, et al.
Published: (2015-03-01)

Genetic Deficiency of MicroRNA-15a/16-1 Confers Resistance to Neuropathological Damage and Cognitive Dysfunction in Experimental Vascular Cognitive Impairment and Dementia
by: Chen, Y., et al.
Published: (2022)

Transcranial Doppler ultrasound in vascular cognitive impairment-no dementia.
by: Luisa Vinciguerra, et al.
Published: (2019-01-01)

Brain Microvascular Pericytes in Vascular Cognitive Impairment and Dementia
by: Maiko T. Uemura, et al.
Published: (2020-04-01)

Association of vascular function and cognitive impairment no dementia (CIND)
by: Braslavsky, Anna
Published: (2011)

Amyloid Imaging in Aging and Dementia: Testing the Amyloid Hypothesis In Vivo
by: G. D. Rabinovici, et al.
Published: (2009-01-01)

Serum levels of proteins involved in amyloid‐β clearance are related to cognitive decline and neuroimaging changes in mild cognitive impairment
by: Shan Liu, et al.
Published: (2019-12-01)

Cannot write session to /tmp/vufind_sessions/sess_c7mnrqdvpi96heqt3fke1utmqe